Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-25 @ 3:52 AM
NCT ID:
NCT01675102
Eligibility Criteria:
Inclusion Criteria:
* 17p-/p53-mutated CLL by FISH or sequencing, confirmed by review by an experienced laboratory
* first or second partial remission or complete remission at HCT according to the updated NCI-criteria (Hallek 2008)
* MRD diagnostic as part of the local standard follow up
* allogeneic HCT from a matched related or unrelated donor with up to one mismatch refering to HLA-A, -B, -C and DRB1
Exclusion Criteria:
* ex vivo T-cell depletion
* in vivo T-cell depletion with alemtuzumab
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
69 Years
Study:
NCT01675102
Study Brief:
Protocol Section:
NCT01675102